GSP Neonatal Total Galactose kit

GSP Neonatal Total Galactose kit is an FDA 510(k)-cleared medical device (K190335) manufactured by Perkinelmer, Inc.. This device is classified under the Clinical Chemistry specialty. FDA Device Class I (General Controls) — lowest risk category. FDA clearance granted on November 5, 2019. Regulation: 8.